Recursion Pharmaceuticals (RXRX) Invested Capital (2020 - 2026)
Recursion Pharmaceuticals' Invested Capital came in at $929.2 million for Q2 2026, down 1.4% from $942.09 million a year earlier and down 10.8% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Invested Capital (2020 - 2026) Analysis & Trends
For FY2025, Recursion Pharmaceuticals' Invested Capital was $1.15 billion, up 8.2% from FY2024.
- Going back by year, Invested Capital was $1.06 billion in FY2024 (+128.6%), $464.62 million in FY2023 (-4.5%), $486.44 million in FY2022 (-10.5%) and $543.66 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Invested Capital since Q3 2024.
- Year-over-year, Invested Capital increased in seven of the last eight quarters, with growth averaging 56.8%.
- The fastest year-over-year change in Invested Capital over five years came in Q1 2025 (growth of 138.4%), and the weakest in Q3 2022 (a decline of 35.2%).
- Business Quant data shows RXRX's Invested Capital at $1.04 billion (Q1 2026), $1.15 billion (Q4 2025) and $1.07 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn | 929.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 929.20 Mn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 942.09 Mn |
| Mar 31, 2025 | 958.98 Mn |
| Dec 31, 2024 | 1.06 Bn |
| Sep 30, 2024 | 553.29 Mn |
| Jun 30, 2024 | 615.48 Mn |
| Mar 31, 2024 | 402.28 Mn |
| Dec 31, 2023 | 464.62 Mn |
| Sep 30, 2023 | 439.79 Mn |
| Jun 30, 2023 | 470.79 Mn |
| Mar 31, 2023 | 432.02 Mn |
| Dec 31, 2022 | 486.44 Mn |
| Sep 30, 2022 | 388.69 Mn |
| Jun 30, 2022 | 438.26 Mn |
| Mar 31, 2022 | 494.27 Mn |
| Dec 31, 2021 | 543.66 Mn |
| Sep 30, 2021 | 599.78 Mn |
API Access
Recursion Pharmaceuticals Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();